Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1943 Feb 1;77(2):165–171. doi: 10.1084/jem.77.2.165

THE LS-ANTIGEN OF VACCINIA

IV. CHEMICAL ANALYSIS OF LS AND THE EFFECT OF CHYMOTRYPSIN ON LS

Joseph E Smadel 1, Charles L Hoagland 1, Theodore Shedlovsky 1
PMCID: PMC2135326  PMID: 19871272

Abstract

Pure LS-antigen of vaccinia contains 15.8 per cent N and 50.6 per cent C. These analytical data together with the absence of lipids, phosphorus, nucleic acid, and glucosamine in preparations of the antigen confirm the protein nature of the substance. The action of proteolytic enzymes on LS offers further confirmation of the protein character of the antigen. Both the L- and S-activities of the antigen are destroyed by digestion with papain. The effects of crystalline chymotrypsin on LS-antigen are particularly interesting for, under proper conditions, this enzyme destroys the serological activity of the S-portion of the molecule without affecting the L-portion. This newly prepared degradation product of LS, called LS'', contains the same amount of N as the native substance but unlike LS, it forms needle-shaped crystalloids.

Full Text

The Full Text of this article is available as a PDF (383.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Craigie J., Wishart F. O. STUDIES ON THE SOLUBLE PRECIPITABLE SUBSTANCES OF VACCINIA : II. THE SOLUBLE PRECIPITABLE SUBSTANCES OF DERMAL VACCINE. J Exp Med. 1936 Oct 31;64(5):819–830. doi: 10.1084/jem.64.5.819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Hoagland C. L., Smadel J. E., Rivers T. M. CONSTITUENTS OF ELEMENTARY BODIES OF VACCINIA : I. CERTAIN BASIC ANALYSES AND OBSERVATIONS ON LIPID COMPONENTS OF THE VIRUS. J Exp Med. 1940 May 31;71(6):737–750. doi: 10.1084/jem.71.6.737. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Hoagland C. L., Ward S. M., Smadel J. E., Rivers T. M. CONSTITUENTS OF ELEMENTARY BODIES OF VACCINIA : III. THE EFFECT OF PURIFIED ENZYMES ON ELEMENTARY BODIES OF VACCINIA. J Exp Med. 1940 Nov 30;72(6):685–696. doi: 10.1084/jem.72.6.685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Parker R. F. IMMUNOLOGICAL STUDIES OF A HEAT-STABLE SUBSTANCE ISOLATED FROM TISSUES INFECTED WITH VACCINE VIRUS. J Exp Med. 1938 Feb 28;67(3):361–367. doi: 10.1084/jem.67.3.361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Parker R. F., Rivers T. M. IMMUNOLOGICAL AND CHEMICAL INVESTIGATIONS OF VACCINE VIRUS : VI. ISOLATION OF A HEAT-STABLE, SEROLOGICALLY ACTIVE SUBSTANCE FROM TISSUES INFECTED WITH VACCINE VIRUS. J Exp Med. 1937 Jan 31;65(2):243–249. doi: 10.1084/jem.65.2.243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Shedlovsky T., Rothen A., Smadel J. E. THE LS-ANTIGEN OF VACCINIA : III. PHYSICAL-CHEMICAL PROPERTIES OF LS-ANTIGEN AND SOME OF ITS DEGRADATION PRODUCTS. J Exp Med. 1943 Feb 1;77(2):155–164. doi: 10.1084/jem.77.2.155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Shedlovsky T., Smadel J. E. THE LS-ANTIGEN OF VACCINIA : II. ISOLATION OF A SINGLE SUBSTANCE CONTAINING BOTH L- AND S-ACTIVITY. J Exp Med. 1942 Jan 31;75(2):165–178. doi: 10.1084/jem.75.2.165. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES